JWH-198
Overview[edit]
JWH-198 is a synthetic cannabinoid that acts as a potent agonist at the cannabinoid receptors. It is part of the naphthoylindole family of compounds, which are known for their psychoactive effects similar to those of tetrahydrocannabinol (THC), the active component in cannabis.
Chemical Structure[edit]
JWH-198 is chemically classified as a naphthoylindole, with the full chemical name being 1-Pentyl-3-(4-methoxynaphthoyl)indole. The structure consists of a naphthalene ring system attached to an indole core, with a methoxy group at the 4-position of the naphthalene ring and a pentyl chain at the 1-position of the indole.
Pharmacology[edit]
JWH-198 functions as a full agonist at both the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including mood, appetite, and pain sensation.
CB1 Receptor[edit]
The CB1 receptor is primarily found in the central nervous system, and its activation by JWH-198 can lead to psychoactive effects similar to those produced by THC.
CB2 Receptor[edit]
The CB2 receptor is mainly located in the immune system and peripheral tissues. Activation of this receptor by JWH-198 is associated with anti-inflammatory effects and modulation of immune responses.
Legal Status[edit]
The legal status of JWH-198 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. It is often included in legislation targeting synthetic cannabinoids and "designer drugs."
Potential Effects and Risks[edit]
The use of JWH-198, like other synthetic cannabinoids, can lead to a range of effects, including euphoria, altered perception, and relaxation. However, it can also cause adverse effects such as anxiety, paranoia, and in some cases, severe health complications.
Related Compounds[edit]
JWH-198 is part of a larger group of synthetic cannabinoids, including JWH-018, JWH-073, and JWH-250, which share similar structures and pharmacological profiles.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
